Trials / Completed
CompletedNCT05658107
A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses of BI 765423 in Healthy Male Subjects (Single-blind, Randomised, Placebo-controlled, Parallel Group Design)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 765423 in healthy male subjects following intravenous administration of single rising doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 765423 | BI 765423 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2023-01-16
- Primary completion
- 2024-03-19
- Completion
- 2024-03-19
- First posted
- 2022-12-20
- Last updated
- 2024-04-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05658107. Inclusion in this directory is not an endorsement.